Steinberg J J, Tsukamoto S, Sledge C B
Biochim Biophys Acta. 1983 May 4;757(1):47-58. doi: 10.1016/0304-4165(83)90151-4.
Proteoglycan breakdown was studied in a coculture model which mimics the confrontation between synovium and cartilage that occurs in rheumatoid arthritis. Bovine nasal-septum cartilage discs radioactively labeled (35SO2-4 with or without [3H]glucosamine) and 'chased' in non-radioactive medium were cultured in contact with minced rheumatoid synovial membranes for intervals up to 8 days. Synovium-stimulated (2-3-fold) cartilage breakdown was unaffected by ascorbate supplementation. Labeled products (small molecules plus proteoglycan complexes) in culture media were characterized by chromatographic, sedimentation and enzymic digestion methods. Breakdown was dominated by the release of a range of proteoglycan products, fully disaggregated and incapable of reaggregation with added hyaluronate. Because constituent glycosaminoglycans were of uniform size, proteoglycan polydispersity was attributed to differences in core protein length. Hydrocortisone inhibited degradation and partially prevented the shift of proteoglycans to lower average molecular weight. An additional breakdown pattern occasionally noted during the initial 48 h of coculture was characterized by release of a subpopulation of low charge-density proteoglycan bearing shortened glycosaminoglycan chains, consistent with glycosidase action. We conclude that rheumatoid synovia exhibit two distinct cartilage degradative potencies in vitro that may be important in vivo: (a) A variable hyaluronidase-like activity at early culture times, and (b) a dominant proteolytic activity generating an array of disaggregated proteoglycan products that differ largely on the basis of their core lengths. The response to hydrocortisone is consistent with inhibition of proteolysis through the stabilization of cellular membranes.
在一种共培养模型中研究了蛋白聚糖的降解情况,该模型模拟了类风湿性关节炎中滑膜与软骨之间的对抗。将用放射性标记(含或不含[3H]葡萄糖胺的35SO2-4)并在非放射性培养基中“追踪”的牛鼻中隔软骨圆盘与切碎的类风湿性滑膜接触培养长达8天。滑膜刺激的(2 - 3倍)软骨降解不受补充抗坏血酸的影响。通过色谱、沉降和酶消化方法对培养基中的标记产物(小分子加蛋白聚糖复合物)进行了表征。降解主要表现为一系列蛋白聚糖产物的释放,这些产物完全解聚且不能与添加的透明质酸重新聚集。由于组成糖胺聚糖大小均匀,蛋白聚糖的多分散性归因于核心蛋白长度的差异。氢化可的松抑制降解并部分阻止蛋白聚糖向较低平均分子量的转变。在共培养的最初48小时偶尔观察到的另一种降解模式的特征是释放出一群低电荷密度的蛋白聚糖,其糖胺聚糖链缩短,这与糖苷酶的作用一致。我们得出结论,类风湿性滑膜在体外表现出两种不同的软骨降解能力,这在体内可能很重要:(a)在培养早期具有可变的类透明质酸酶活性,以及(b)一种占主导地位的蛋白水解活性,产生一系列主要因其核心长度不同而不同的解聚蛋白聚糖产物。对氢化可的松的反应与通过稳定细胞膜来抑制蛋白水解一致。